These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. Kenna JG; Satoh H; Christ DD; Pohl LR J Pharmacol Exp Ther; 1988 Jun; 245(3):1103-9. PubMed ID: 3385639 [TBL] [Abstract][Full Text] [Related]
7. Halothane hepatitis 28 years after primary exposure. Martin JL; Dubbink DA; Plevak DJ; Peronne A; Taswell HF; Hay EJ; Pumford NR; Pohl LR Anesth Analg; 1992 Apr; 74(4):605-8. PubMed ID: 1554130 [No Abstract] [Full Text] [Related]
11. S-ethylthiotrifluoroacetate enhancement of the immune response to halothane in the guinea pig. Hastings KL; Schuman S; Brown AP; Thomas C; Gandolfi AJ Adv Exp Med Biol; 1991; 283():739-44. PubMed ID: 2069050 [No Abstract] [Full Text] [Related]
13. [Halothane hepatitis and allergy]. Okumura F Masui; 1970 Jul; 19(7):704-9. PubMed ID: 4915665 [No Abstract] [Full Text] [Related]
14. Halothane hepatitis: a model of immune mediated drug hepatotoxicity. Neuberger J; Kenna JG Clin Sci (Lond); 1987 Mar; 72(3):263-70. PubMed ID: 3545644 [No Abstract] [Full Text] [Related]
15. Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. Paronetto F; Popper H N Engl J Med; 1970 Aug; 283(6):277-80. PubMed ID: 5448331 [No Abstract] [Full Text] [Related]